[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 227
Citations 0
Comment & Response
March 2016

Neuraminidase Inhibitors and Influenza Infection

Author Affiliations
  • 1Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
JAMA Intern Med. 2016;176(3):415. doi:10.1001/jamainternmed.2016.0013

To the Editor Louie and Lampiris1 summarize current evidence for the treatment of influenza infection with neuraminidase inhibitors. At first, they discuss the persistent uncertainty and inadequate evidence regarding the effectiveness of neuraminidase inhibitors in outpatients at risk for severe disease and in hospitalized patients. But they then come full circle and recommend prompt treatment of these patients based on data from observational studies and ethical concerns that would preclude randomized clinical trials.

First Page Preview View Large
First page PDF preview
First page PDF preview
×